$INUV
Inuvo, Inc. Stock $inuv

$inuv Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000165495424002423 Filed on February 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$17.02M	$20.84M	$73.91M
YoY Change	43.69%	20.68%	-2.24%
Cost Of Revenue	$2.099M	$2.644M	$10.48M
YoY Change	-34.21%	-52.17%	-65.36%
Gross Profit	$14.92M	$18.20M	$63.43M
YoY Change	72.4%	54.97%	39.85%
Gross Profit Margin	87.67%	87.32%	85.82%
Selling, General & Admin	$17.02M	$20.63M	$73.83M
YoY Change	40.72%	31.57%	755.96%
% of Gross Profit	114.01%	113.34%	116.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$673.2K	$691.6K	$2.655M
YoY Change	5.35%	1.74%	2.17%
% of Gross Profit	4.51%	3.8%	4.19%
Operating Expenses	$17.02M	$20.63M	$73.83M
YoY Change	40.72%	31.57%	27.27%
Operating Profit	-$2.091M	-$2.427M	-$10.39M
YoY Change	-39.13%	-38.28%	-17.84%
Interest Expense	-$20.38K	$7.880K	-$29.57K
YoY Change	6.59%	-178.56%	40.08%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	$14.67K
YoY Change	-100.0%	-100.0%	-103.37%
Pretax Income	-$2.112M	-$2.419M	-$10.41M
YoY Change	-38.62%	-39.17%	-20.59%
Income Tax		-$17.76K	$17.76K
% Of Pretax Income
Net Earnings	-$2.112M	-$2.401M	-$10.39M
YoY Change	-38.62%	-39.62%	-20.69%
Net Earnings / Revenue	-12.4%	-11.52%	-14.06%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.02	-$0.02	-$0.08
COMMON SHARES
Basic Shares Outstanding	139.2M shares	138.0M shares	131.1M shares
Diluted Shares Outstanding	138.8M shares		131.1M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.432M	$4.440M	$4.440M
YoY Change	23.48%	-0.46%	-0.46%
Cash & Equivalents	$2.000M	$4.440M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$1.019M	$1.076M	$1.076M
YoY Change	4.99%	34.69%	34.69%
Inventory
Prepaid Expenses	$1.019M	$1.076M
Receivables	$8.710M	$9.227M	$9.227M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$12.16M	$14.74M	$14.74M
YoY Change	0.83%	-9.99%	-9.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.726M	$1.681M	$2.559M
YoY Change	2.29%	0.71%	19.15%
Goodwill	$9.853M	$9.853M
YoY Change	0.0%	0.0%
Intangibles	$4.419M	$4.665M
YoY Change	-18.22%	-17.43%
Long-Term Investments		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Assets	$53.35K	$53.35K	$553.4K
YoY Change	-20.28%	-20.28%	-36.17%
Total Long-Term Assets	$17.61M	$17.63M	$17.63M
YoY Change	-2.65%	-8.07%	-8.07%
TOTAL ASSETS
Total Short-Term Assets	$12.16M	$14.74M	$14.74M
Total Long-Term Assets	$17.61M	$17.63M	$17.63M
Total Assets	$29.78M	$32.37M	$32.37M
YoY Change	-1.26%	-8.95%	-8.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.331M	$6.432M	$6.432M
YoY Change	-3.2%	-20.05%	-20.05%
Accrued Expenses	$8.030M	$7.926M	$8.043M
YoY Change	62.79%	53.54%	47.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$38.19K	$50.80K	$50.80K
YoY Change	-55.74%	-49.7%	-49.7%
Total Short-Term Liabilities	$13.63M	$14.53M	$14.53M
YoY Change	20.34%	6.89%	6.89%
LONG-TERM LIABILITIES
Long-Term Debt	$12.12K	$18.21K	$18.21K
YoY Change	-76.17%	-74.21%	-74.21%
Other Long-Term Liabilities	$0.00	$216.00	$752.0K
YoY Change	-100.0%	-97.99%	2072.9%
Total Long-Term Liabilities	$1.037M	$859.5K	$770.3K
YoY Change	484.64%	305.02%	632.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.63M	$14.53M	$14.53M
Total Long-Term Liabilities	$1.037M	$859.5K	$770.3K
Total Liabilities	$14.67M	$15.39M	$15.39M
YoY Change	27.5%	11.47%	11.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$169.6M	-$167.4M
YoY Change	5.64%	6.59%
Common Stock	$139.4K	$138.0K
YoY Change	14.62%	14.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.10M	$16.98M	$16.98M
YoY Change
Total Liabilities & Shareholders Equity	$29.78M	$32.37M	$32.37M
YoY Change	-1.26%	-8.95%	-8.95%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.112M	-$2.401M	-$10.39M
YoY Change	-38.62%	-39.62%	-20.69%
Depreciation, Depletion And Amortization	$673.2K	$691.6K	$2.655M
YoY Change	5.35%	1.74%	2.17%
Cash From Operating Activities	-$1.356M	-$2.094M	-$2.554M
YoY Change	-58.04%	-23.95%	-54.39%
INVESTING ACTIVITIES
Capital Expenditures	$472.2K	$422.7K	$1.683M
YoY Change	14.83%	11.66%	-0.43%
Acquisitions
YoY Change
Other Investing Activities		-$1.130K	$2.289M
YoY Change		-100.36%	9541.41%
Cash From Investing Activities	-$472.2K	-$423.8K	$606.2K
YoY Change	-125.15%	560.86%	-136.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$3.665M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$180.7K	-23.08K	$3.457M
YoY Change	-146.15%	-27.17%	-1235.53%
NET CHANGE
Cash From Operating Activities	-$1.356M	-2.094M	-$2.554M
Cash From Investing Activities	-$472.2K	-423.8K	$606.2K
Cash From Financing Activities	-$180.7K	-23.08K	$3.457M
Net Change In Cash	-$2.008M	-2.541M	$1.509M
YoY Change	108.82%	-10.83%	-120.0%
FREE CASH FLOW
Cash From Operating Activities	-$1.356M	-$2.094M	-$2.554M
Capital Expenditures	$472.2K	$422.7K	$1.683M
Free Cash Flow	-$1.828M	-$2.517M	-$4.237M
YoY Change	-49.82%	-19.65%	-41.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.71
CY2021Q3	inuvo	Warrants Outstanding Term WarrantsOutstandingTerm	P7Y
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.04	pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000829323
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	137983918	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120137124	shares
CY2023	inuvo	Pending Number Of Patents PendingNumberOfPatents	8	integer
CY2023	dei	Entity File Number EntityFileNumber	001-32442
CY2023	dei	Entity Registrant Name EntityRegistrantName	INUVO, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0450450
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	72201
CY2023	dei	City Area Code CityAreaCode	501
CY2023	dei	Local Phone Number LocalPhoneNumber	205-8508
CY2023	dei	Security12b Title Security12bTitle	Common Stock
CY2021Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2000000	usd
CY2023	inuvo	Number Of Employees Employed Under Grant NumberOfEmployeesEmployedUnderGrant	48	integer
CY2023	inuvo	Number Of Employees Under Minimum Amount Required To Be Employed Under Grant NumberOfEmployeesUnderMinimumAmountRequiredToBeEmployedUnderGrant	2	integer
CY2022	inuvo	Number Of Employees Under Minimum Amount Required To Be Employed Under Grant NumberOfEmployeesUnderMinimumAmountRequiredToBeEmployedUnderGrant	2	integer
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	integer
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	9853342	usd
CY2022Q4	inuvo	Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross	17565000	usd
CY2021Q3	inuvo	Referral Agreement Term ReferralAgreementTerm	P5Y
CY2021Q3	inuvo	Class Of Warrant Or Right Vesting Period ClassOfWarrantOrRightVestingPeriod	P2Y
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2023	inuvo	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0	pure
CY2021Q3	inuvo	Referral Agreement Term ReferralAgreementTerm	P5Y
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.71
CY2021Q3	inuvo	Warrants Outstanding Term WarrantsOutstandingTerm	P7Y
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.04	pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Entity File Number EntityFileNumber	001-32442
CY2023	dei	Entity Registrant Name EntityRegistrantName	INUVO, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0450450
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 President Clinton Ave.
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Little Rock
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	AR
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	72201
CY2023	dei	City Area Code CityAreaCode	501
CY2023	dei	Local Phone Number LocalPhoneNumber	205-8508
CY2023	dei	Security12b Title Security12bTitle	Common Stock
CY2023	dei	Trading Symbol TradingSymbol	INUV
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	27900000	usd
CY2023	dei	Auditor Name AuditorName	EISNERAMPER LLP
CY2023	dei	Auditor Location AuditorLocation	Iselin, New Jersey
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4440454	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2931415	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1529464	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1645045	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1440678	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9226956	usd
CY2023	dei	Trading Symbol TradingSymbol	INUV
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	27900000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	139220784	shares
CY2023	dei	Auditor Firm AuditorFirmId	274
CY2023	dei	Auditor Name AuditorName	EISNERAMPER LLP
CY2023	dei	Auditor Location AuditorLocation	Iselin, New Jersey
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4440454	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2931415	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1529464	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1645045	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1440678	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9226956	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11119892	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1076121	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	798977	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	14743531	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	16379748	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1668972	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	805786	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	310162	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	72560	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	168750	usd
CY2023Q4	inuvo	Referral Agreement ReferralAgreement	500000	usd
CY2022Q4	inuvo	Referral Agreement ReferralAgreement	800000	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	660126	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4664791	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5649291	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9853342	usd
CY2022Q4	us-gaap	Goodwill Goodwill	9853342	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53346	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	66919	usd
CY2023Q4	inuvo	Other Assets Total Noncurrent OtherAssetsTotalNoncurrent	15949825	usd
CY2022Q4	inuvo	Other Assets Total Noncurrent OtherAssetsTotalNoncurrent	17508590	usd
CY2023Q4	us-gaap	Assets Assets	32374144	usd
CY2022Q4	us-gaap	Assets Assets	35557310	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6432120	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8044802	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7926479	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5162458	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	123074	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	287523	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	50801	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	101003	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11119892	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1076121	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	798977	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	14743531	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	16379748	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1680788	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1668972	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	805786	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	310162	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	72560	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	168750	usd
CY2023Q4	inuvo	Referral Agreement ReferralAgreement	500000	usd
CY2022Q4	inuvo	Referral Agreement ReferralAgreement	800000	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	660126	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4664791	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5649291	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9853342	usd
CY2022Q4	us-gaap	Goodwill Goodwill	9853342	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53346	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	66919	usd
CY2023Q4	inuvo	Other Assets Total Noncurrent OtherAssetsTotalNoncurrent	15949825	usd
CY2022Q4	inuvo	Other Assets Total Noncurrent OtherAssetsTotalNoncurrent	17508590	usd
CY2023Q4	us-gaap	Assets Assets	32374144	usd
CY2022Q4	us-gaap	Assets Assets	35557310	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6432120	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8044802	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7926479	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5162458	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	123074	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	287523	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	50801	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	101003	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14532474	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13595786	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	89238	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	107000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	751821	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23878	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	18209	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	70597	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	216	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10733	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	859484	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	212208	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	137983918	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120137124	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	137983	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14532474	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13595786	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	89238	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	107000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	751821	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23878	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	18209	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	70597	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	859484	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	212208	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	137983918	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120137124	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	137983	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	120138	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	184291414	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	178771604	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-84868	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-167447211	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-157057558	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16982186	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21749316	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32374144	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35557310	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	73911528	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	75603745	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10477272	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	30244387	usd
CY2023	us-gaap	Gross Profit GrossProfit	63434256	usd
CY2022	us-gaap	Gross Profit GrossProfit	45359358	usd
CY2023	inuvo	Advertising Costs AdvertisingCosts	51982572	usd
CY2022	inuvo	Advertising Costs AdvertisingCosts	36921139	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	13793309	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	12463095	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8050890	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8624998	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	73826771	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	58009232	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-10392515	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-12649874	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17764	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	inuvo	Finance Lease Principal Payments Other FinanceLeasePrincipalPaymentsOther	29570	usd
CY2022	inuvo	Finance Lease Principal Payments Other FinanceLeasePrincipalPaymentsOther	21111	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14668	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-435554	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-10389653	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13106539	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	120138	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	184291414	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	178771604	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-84868	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-167447211	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-157057558	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16982186	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21749316	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32374144	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35557310	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	73911528	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	75603745	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10477272	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	30244387	usd
CY2023	us-gaap	Gross Profit GrossProfit	63434256	usd
CY2022	us-gaap	Gross Profit GrossProfit	45359358	usd
CY2023	inuvo	Advertising Costs AdvertisingCosts	51982572	usd
CY2022	inuvo	Advertising Costs AdvertisingCosts	36921139	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	13793309	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	12463095	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8050890	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8624998	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	73826771	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	58009232	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-10392515	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-12649874	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17764	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	inuvo	Finance Lease Principal Payments Other FinanceLeasePrincipalPaymentsOther	29570	usd
CY2022	inuvo	Finance Lease Principal Payments Other FinanceLeasePrincipalPaymentsOther	21111	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14668	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-435554	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-10389653	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13106539	usd
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	84868	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-138605	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10304785	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13245144	usd
CY2023	inuvo	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.08
CY2022	inuvo	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.11
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131116370	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	119826036	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131116370	shares
CY2022	inuvo	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Values AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues	2350314	usd
CY2022	inuvo	Stock Issued For Vested Restricted Stock Awards Amount StockIssuedForVestedRestrictedStockAwardsAmount	0	usd
CY2022	inuvo	Shares Withheld For Taxes On Vested Restricted Stock SharesWithheldForTaxesOnVestedRestrictedStock	-196892	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	33043	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21749316	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-10389653	usd
CY2023	inuvo	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Values AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues	1986296	usd
CY2023	inuvo	Stock Issued For Vested Restricted Stock Awards Amount StockIssuedForVestedRestrictedStockAwardsAmount	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3665000	usd
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	84868	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-138605	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10304785	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13245144	usd
CY2023	inuvo	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.08
CY2022	inuvo	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.11
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131116370	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	119826036	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131116370	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119826036	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	32807995	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13106539	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-138605	usd
CY2022	inuvo	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Values AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues	2350314	usd
CY2022	inuvo	Stock Issued For Vested Restricted Stock Awards Amount StockIssuedForVestedRestrictedStockAwardsAmount	0	usd
CY2022	inuvo	Shares Withheld For Taxes On Vested Restricted Stock SharesWithheldForTaxesOnVestedRestrictedStock	-196892	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	33043	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21749316	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-10389653	usd
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	84868	usd
CY2023	inuvo	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Values AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues	1986296	usd
CY2023	inuvo	Stock Issued For Vested Restricted Stock Awards Amount StockIssuedForVestedRestrictedStockAwardsAmount	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3665000	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	166872	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	61136	usd
CY2023	inuvo	Reversal Of Expense Related To Change In Warrant Vesting ReversalOfExpenseRelatedToChangeInWarrantVesting	-7905	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16982186	usd
CY2023	us-gaap	Profit Loss ProfitLoss	10389653	usd
CY2022	us-gaap	Profit Loss ProfitLoss	13106539	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2655368	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2598957	usd
CY2023	inuvo	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	96190	usd
CY2022	inuvo	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	103926	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1986296	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2350314	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	14668	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-435554	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8333	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2500	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	786549	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1265143	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7905	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	33043	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17764	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	inuvo	Grant Expense Derecognition Of Contingencies And Grants GrantExpenseDerecognitionOfContingenciesAndGrants	0	usd
CY2022	inuvo	Grant Expense Derecognition Of Contingencies And Grants GrantExpenseDerecognitionOfContingenciesAndGrants	-10000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1106387	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3119222	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-300000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-300000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	263569	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-578009	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	166872	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	61136	usd
CY2023	inuvo	Reversal Of Expense Related To Change In Warrant Vesting ReversalOfExpenseRelatedToChangeInWarrantVesting	-7905	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16982186	usd
CY2023	us-gaap	Profit Loss ProfitLoss	10389653	usd
CY2022	us-gaap	Profit Loss ProfitLoss	13106539	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2655368	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2598957	usd
CY2023	inuvo	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	96190	usd
CY2022	inuvo	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	103926	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1986296	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2350314	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	14668	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-435554	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8333	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2500	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	786549	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1265143	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7905	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	33043	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17764	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	inuvo	Grant Expense Derecognition Of Contingencies And Grants GrantExpenseDerecognitionOfContingenciesAndGrants	0	usd
CY2022	inuvo	Grant Expense Derecognition Of Contingencies And Grants GrantExpenseDerecognitionOfContingenciesAndGrants	-10000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1106387	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3119222	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-300000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-300000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	263569	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-578009	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2813043	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-205762	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1693963	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2288873	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1717707	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	606190	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1666125	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	592868	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	592868	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3665000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	102340	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	107539	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	166872	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	196894	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	61136	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2813043	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-205762	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5573991	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1682683	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1689869	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1693963	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2288873	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	606190	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1666125	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	592868	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	592868	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3665000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	107539	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	196894	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	61136	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1509039	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7544549	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	70774	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1105148	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023	inuvo	Issued Number Of Patents IssuedNumberOfPatents	19	integer
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	8000000	usd
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	6250000	usd
CY2021Q1	inuvo	Cash Deposited Interest Bearing CashDepositedInterestBearing	10000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	4400000	usd
CY2023Q4	inuvo	Working Capital Net WorkingCapitalNet	211100	usd
CY2023	inuvo	Income Loss Amount IncomeLossAmount	-10300000	usd
CY2023	inuvo	Net Cash Provided By Used In Operating Activities Net NetCashProvidedByUsedInOperatingActivitiesNet	-2600000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1700000	usd
CY2023Q4	inuvo	Accumulated Deficit AccumulatedDeficit	-167400000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-304433	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1509039	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7544549	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2931415	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10475964	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4440454	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2931415	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	18612	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	70774	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1105148	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023	inuvo	Issued Number Of Patents IssuedNumberOfPatents	19	integer
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	8000000	usd
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	6250000	usd
CY2021Q1	inuvo	Cash Deposited Interest Bearing CashDepositedInterestBearing	10000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	4400000	usd
CY2023Q4	inuvo	Working Capital Net WorkingCapitalNet	211100	usd
CY2023	inuvo	Income Loss Amount IncomeLossAmount	-10300000	usd
CY2023	inuvo	Net Cash Provided By Used In Operating Activities Net NetCashProvidedByUsedInOperatingActivitiesNet	-2600000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1700000	usd
CY2023Q4	inuvo	Accumulated Deficit AccumulatedDeficit	-167400000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	73911528	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	75603745	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	73911528	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	75603745	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9226956	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11119892	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9265813	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9226956	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11119892	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9265813	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9226956	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11119892	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9265813	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9226956	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11119892	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9265813	usd
CY2023	us-gaap	Depreciation Depreciation	1670868	usd
CY2022	us-gaap	Depreciation Depreciation	1527663	usd
CY2023	us-gaap	Depreciation Depreciation	1670868	usd
CY2022	us-gaap	Depreciation Depreciation	1527663	usd
CY2023	inuvo	Number Of Employees Required To Be Employed Under Grant NumberOfEmployeesRequiredToBeEmployedUnderGrant	50	integer
CY2023Q4	inuvo	Contingent Liability Current ContingentLiabilityCurrent	35000	usd
CY2022	inuvo	Number Of Employees Employed Under Grant NumberOfEmployeesEmployedUnderGrant	48	integer
CY2022	inuvo	Number Of Employees Required To Be Employed Under Grant NumberOfEmployeesRequiredToBeEmployedUnderGrant	50	integer
CY2022Q4	inuvo	Contingent Liability Current ContingentLiabilityCurrent	10000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Concentration of credit risk</span> - We are exposed to concentrations of risk primarily in cash and accounts receivable, which are generally not collateralized. Our policy is to place our cash with high credit, quality financial institutions in order to limit the amount of credit exposure. Our cash deposits exceed FDIC limits. We do not require collateral from our customers, but our credit extension and collection policies include monitoring payments and aggressively pursuing delinquent accounts. We maintain allowances for potential credit losses. </p>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1440678	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1645045	usd
CY2023	inuvo	Number Of Employees Required To Be Employed Under Grant NumberOfEmployeesRequiredToBeEmployedUnderGrant	50	integer
CY2023Q4	inuvo	Contingent Liability Current ContingentLiabilityCurrent	35000	usd
CY2022	inuvo	Number Of Employees Employed Under Grant NumberOfEmployeesEmployedUnderGrant	48	integer
CY2022	inuvo	Number Of Employees Required To Be Employed Under Grant NumberOfEmployeesRequiredToBeEmployedUnderGrant	50	integer
CY2022Q4	inuvo	Contingent Liability Current ContingentLiabilityCurrent	10000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Concentration of credit risk</span> - We are exposed to concentrations of risk primarily in cash and accounts receivable, which are generally not collateralized. Our policy is to place our cash with high credit, quality financial institutions in order to limit the amount of credit exposure. Our cash deposits exceed FDIC limits. We do not require collateral from our customers, but our credit extension and collection policies include monitoring payments and aggressively pursuing delinquent accounts. We maintain allowances for potential credit losses. </p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Use of estimates</span> - The preparation of financial statements, in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"), requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, net revenues and expenses and disclosure of contingent assets and liabilities. The estimates and assumptions used in the accompanying consolidated financial statements are based upon management’s regular evaluation of the relevant facts and circumstances as of the date of the consolidated financial statements. We regularly evaluate estimates and assumptions related to goodwill and purchased intangible asset valuations and income tax valuation allowance. Actual results may differ from the estimates and assumptions used in preparing the accompanying consolidated financial statements, and such differences could be material.</p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Use of estimates</span> - The preparation of financial statements, in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"), requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, net revenues and expenses and disclosure of contingent assets and liabilities. The estimates and assumptions used in the accompanying consolidated financial statements are based upon management’s regular evaluation of the relevant facts and circumstances as of the date of the consolidated financial statements. We regularly evaluate estimates and assumptions related to goodwill and purchased intangible asset valuations and income tax valuation allowance. Actual results may differ from the estimates and assumptions used in preparing the accompanying consolidated financial statements, and such differences could be material.</p>
CY2023	inuvo	Marketable Securities Gross Realized Gain Loss MarketableSecuritiesGrossRealizedGainLoss	-510000000	usd
CY2023	inuvo	Marketable Securities Gross Realized Gain Loss MarketableSecuritiesGrossRealizedGainLoss	-510000000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1440678	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	202904	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	786549	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1265143	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	582189	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	27369	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	7	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1645045	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1440678	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	202904	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	786549	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1265143	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	582189	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	27369	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	7	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1645045	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1440678	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1645045	usd
CY2023	inuvo	Increase Decrease In Allowance For Doubtful Accounts Receivable IncreaseDecreaseInAllowanceForDoubtfulAccountsReceivable	204367	usd
CY2023	inuvo	Concentration Risk Percentage ConcentrationRiskPercentage	0.241	pure
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18204082	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16521397	usd
CY2023	us-gaap	Depreciation Depreciation	1670868	usd
CY2023Q4	inuvo	Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross	17565000	usd
CY2023Q4	inuvo	Intangible Assets Accumulated Amortizationand Impairment Loss IntangibleAssetsAccumulatedAmortizationandImpairmentLoss	12900209	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4664791	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9853342	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	9853342	usd
CY2023Q4	inuvo	Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross	17565000	usd
CY2022Q4	inuvo	Intangible Assets Accumulated Amortizationand Impairment Loss IntangibleAssetsAccumulatedAmortizationandImpairmentLoss	11915709	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5649291	usd
CY2023	inuvo	Increase Decrease In Allowance For Doubtful Accounts Receivable IncreaseDecreaseInAllowanceForDoubtfulAccountsReceivable	204367	usd
CY2023	inuvo	Concentration Risk Percentage ConcentrationRiskPercentage	0.241	pure
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18204082	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16521397	usd
CY2023	us-gaap	Depreciation Depreciation	1670868	usd
CY2022	us-gaap	Depreciation Depreciation	1527663	usd
CY2023Q4	inuvo	Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross	17565000	usd
CY2023Q4	inuvo	Intangible Assets Accumulated Amortizationand Impairment Loss IntangibleAssetsAccumulatedAmortizationandImpairmentLoss	12900209	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4664791	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9853342	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	9853342	usd
CY2023Q4	inuvo	Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross	17565000	usd
CY2022Q4	inuvo	Intangible Assets Accumulated Amortizationand Impairment Loss IntangibleAssetsAccumulatedAmortizationandImpairmentLoss	11915709	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5649291	usd
CY2022Q4	us-gaap	Goodwill Goodwill	9853342	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	9853342	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	769917	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	469500	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	469500	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	469500	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	469500	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1626874	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4274791	usd
CY2022Q4	us-gaap	Goodwill Goodwill	9853342	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	9853342	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	769917	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	469500	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	469500	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	469500	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	469500	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1626874	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4274791	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5717983	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	3321598	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	622960	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1044664	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1544460	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	782441	usd
CY2023Q4	inuvo	Accrued Grant Current AccruedGrantCurrent	35000	usd
CY2022Q4	inuvo	Accrued Grant Current AccruedGrantCurrent	10000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6076	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3755	usd
CY2023Q4	inuvo	Accrued Liabilities And Lease Liability Current AccruedLiabilitiesAndLeaseLiabilityCurrent	7926479	usd
CY2022Q4	inuvo	Accrued Liabilities And Lease Liability Current AccruedLiabilitiesAndLeaseLiabilityCurrent	5162458	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5717983	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	3321598	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	622960	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1044664	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1544460	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	782441	usd
CY2023Q4	inuvo	Accrued Grant Current AccruedGrantCurrent	35000	usd
CY2022Q4	inuvo	Accrued Grant Current AccruedGrantCurrent	10000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6076	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3755	usd
CY2023Q4	inuvo	Accrued Liabilities And Lease Liability Current AccruedLiabilitiesAndLeaseLiabilityCurrent	7926479	usd
CY2022Q4	inuvo	Accrued Liabilities And Lease Liability Current AccruedLiabilitiesAndLeaseLiabilityCurrent	5162458	usd
CY2021Q3	inuvo	Referral Agreement For Service Advance ReferralAgreementForServiceAdvance	1500000	usd
CY2023	inuvo	Amortization Of Referral Agreement As Marketing Expense AmortizationOfReferralAgreementAsMarketingExpense	700000	usd
CY2023Q4	inuvo	Referral Agreement For Service Advance ReferralAgreementForServiceAdvance	800000	usd
CY2021Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	300000	shares
CY2023Q3	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	960852000	usd
CY2023Q3	inuvo	Referral Agreement For Service Advance ReferralAgreementForServiceAdvance	642202	usd
CY2023	inuvo	Reduction In Commission Expense ReductionInCommissionExpense	67000	usd
CY2023	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	52000	usd
CY2021Q3	inuvo	Referral Agreement For Service Advance ReferralAgreementForServiceAdvance	1500000	usd
CY2023	inuvo	Amortization Of Referral Agreement As Marketing Expense AmortizationOfReferralAgreementAsMarketingExpense	700000	usd
CY2023Q4	inuvo	Referral Agreement For Service Advance ReferralAgreementForServiceAdvance	800000	usd
CY2021Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	300000	shares
CY2023Q3	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	960852000	usd
CY2023Q3	inuvo	Referral Agreement For Service Advance ReferralAgreementForServiceAdvance	642202	usd
CY2023	inuvo	Reduction In Commission Expense ReductionInCommissionExpense	67000	usd
CY2023	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	52000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17764	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17764	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.03	pure
CY2023	inuvo	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0.04	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.26	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.24	pure
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	17800	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	38860119	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	36506618	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1011900	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	543000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	541200	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	287600	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17764	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17764	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.03	pure
CY2023	inuvo	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0.04	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.26	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.24	pure
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	17800	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	38860119	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	36506618	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1011900	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	543000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	541200	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	287600	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	19200	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	3000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	461000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	403800	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	587900	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	869900	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	122100	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	403500	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	373100	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	41884819	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	19200	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	3000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	461000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	403800	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	587900	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	869900	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	122100	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	403500	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	373100	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	41884819	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	39109118	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	40619657	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	37976018	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1265162	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1133100	usd
CY2023Q4	inuvo	Deferred Tax Liabilities Intangible Assetsand Property Plantand Equipment DeferredTaxLiabilitiesIntangibleAssetsandPropertyPlantandEquipment	826300	usd
CY2022Q4	inuvo	Deferred Tax Liabilities Intangible Assetsand Property Plantand Equipment DeferredTaxLiabilitiesIntangibleAssetsandPropertyPlantandEquipment	1242200	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	528100	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2100	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1354400	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1240100	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	89238	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	107000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	107908005	usd
CY2023	inuvo	Net Operating Losses Expired Period NetOperatingLossesExpiredPeriod	expire beginning 2024 through 2037
CY2023	inuvo	Federal Net Operating Loss Carryforwards FederalNetOperatingLossCarryforwards	30700000	usd
CY2023	inuvo	Federal Net Operating Loss Carryforwards Percentage Rate FederalNetOperatingLossCarryforwardsPercentageRate	0.80	pure
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	89238	usd
CY2023	inuvo	Deferred Tax Liability Relating To Goodwill Offset Percenatge DeferredTaxLiabilityRelatingToGoodwillOffsetPercenatge	0.80	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	24550000	shares
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1986296	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2350314	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1571436	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	7010016	shares
CY2023Q4	inuvo	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Shares Exercised SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesExercised	6634121	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10905863	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	24550000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.52
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000	shares
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	39109118	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	40619657	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	37976018	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1265162	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1133100	usd
CY2023Q4	inuvo	Deferred Tax Liabilities Intangible Assetsand Property Plantand Equipment DeferredTaxLiabilitiesIntangibleAssetsandPropertyPlantandEquipment	826300	usd
CY2022Q4	inuvo	Deferred Tax Liabilities Intangible Assetsand Property Plantand Equipment DeferredTaxLiabilitiesIntangibleAssetsandPropertyPlantandEquipment	1242200	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	528100	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2100	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1354400	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1240100	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	89238	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	107000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	107908005	usd
CY2023	inuvo	Net Operating Losses Expired Period NetOperatingLossesExpiredPeriod	expire beginning 2024 through 2037
CY2023	inuvo	Federal Net Operating Loss Carryforwards FederalNetOperatingLossCarryforwards	30700000	usd
CY2023	inuvo	Federal Net Operating Loss Carryforwards Percentage Rate FederalNetOperatingLossCarryforwardsPercentageRate	0.80	pure
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	89238	usd
CY2023	inuvo	Deferred Tax Liability Relating To Goodwill Offset Percenatge DeferredTaxLiabilityRelatingToGoodwillOffsetPercenatge	0.80	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	24550000	shares
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1986296	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2350314	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1571436	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	7010016	shares
CY2023Q4	inuvo	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Shares Exercised SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesExercised	6634121	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10905863	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	24550000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.52
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.52
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.52
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2021Q3	inuvo	Class Of Warrant Or Right Granted In Period ClassOfWarrantOrRightGrantedInPeriod	300000	shares
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	149551	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	21136	shares
CY2023	inuvo	Stock Warrant Credit StockWarrantCredit	7900	usd
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	370782	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	292825	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	805786	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	72560	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	310162	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	168750	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	96190	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	103926	usd
CY2023	inuvo	Rent Expense Right Of Use Asset Operating Leases RentExpenseRightOfUseAssetOperatingLeases	358667	usd
CY2022	inuvo	Rent Expense Right Of Use Asset Operating Leases RentExpenseRightOfUseAssetOperatingLeases	377020	usd
CY2023Q3	inuvo	Lessee Operating Lease Lease Not Yet Commenced Lease Cost Year One LesseeOperatingLeaseLeaseNotYetCommencedLeaseCostYearOne	208000	usd
CY2023Q3	inuvo	Lessee Operating Lease Annual Increase In Lease Cost Percentage LesseeOperatingLeaseAnnualIncreaseInLeaseCostPercentage	0.03	pure
CY2021Q3	inuvo	Class Of Warrant Or Right Granted In Period ClassOfWarrantOrRightGrantedInPeriod	300000	shares
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	149551	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	85862	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	21136	shares
CY2023	inuvo	Stock Warrant Credit StockWarrantCredit	7900	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	193000	shares
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	370782	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	292825	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	805786	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	72560	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	310162	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	96190	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	103926	usd
CY2023	inuvo	Rent Expense Right Of Use Asset Operating Leases RentExpenseRightOfUseAssetOperatingLeases	358667	usd
CY2022	inuvo	Rent Expense Right Of Use Asset Operating Leases RentExpenseRightOfUseAssetOperatingLeases	377020	usd
CY2023Q3	inuvo	Lessee Operating Lease Lease Not Yet Commenced Lease Cost Year One LesseeOperatingLeaseLeaseNotYetCommencedLeaseCostYearOne	208000	usd
CY2023Q3	inuvo	Lessee Operating Lease Annual Increase In Lease Cost Percentage LesseeOperatingLeaseAnnualIncreaseInLeaseCostPercentage	0.03	pure

Files In Submission

Name	View Source	Status
inuvo-20231231_cal.xml	Edgar Link	unprocessable
inuvo_10k_htm.xml	Edgar Link	completed
0001654954-24-002423-index-headers.html	Edgar Link	pending
0001654954-24-002423-index.html	Edgar Link	pending
0001654954-24-002423.txt	Edgar Link	pending
0001654954-24-002423-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
inuvo-20231231.xsd	Edgar Link	pending
inuvo_10k.htm	Edgar Link	pending
inuvo_10kimg2.jpg	Edgar Link	pending
inuvo_ex101.htm	Edgar Link	pending
inuvo_ex101img2.jpg	Edgar Link	pending
inuvo_ex211.htm	Edgar Link	pending
inuvo_ex231.htm	Edgar Link	pending
inuvo_ex311.htm	Edgar Link	pending
inuvo_ex312.htm	Edgar Link	pending
inuvo_ex321.htm	Edgar Link	pending
inuvo_ex322.htm	Edgar Link	pending
inuvo_ex971.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
inuvo-20231231_def.xml	Edgar Link	unprocessable
inuvo-20231231_lab.xml	Edgar Link	unprocessable
inuvo-20231231_pre.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INUV
Inuvo, Inc. Stock $inuv

2024 Q1 Form 10-K Financial Statement

#000165495424002423 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INUV Inuvo, Inc. Stock $inuv

2024 Q1 Form 10-K Financial Statement

#000165495424002423 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INUV
Inuvo, Inc. Stock $inuv